These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26408642)

  • 21. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
    Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
    Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between the expression of TAM, survivin and the degree of necrosis of the tumor after cisplatin treatment in osteosarcoma.
    Chen G
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):490-497. PubMed ID: 28239822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
    Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
    BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
    Wang YF; Shen JN; Xie XB; Wang J; Huang G
    Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
    Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
    Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.
    Sun L; Li Y; Zhang J; Li H; Li B; Ye Z
    J Orthop Res; 2015 Jan; 33(1):131-9. PubMed ID: 25231396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
    Wang Z; He M; Xiao Z; Wu H; Wu Y
    PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
    Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factor-1 expression predicts osteosarcoma patients' survival: a meta-analysis.
    Ouyang Y; Li H; Bu J; Li X; Chen Z; Xiao T
    Int J Biol Markers; 2016 Jul; 31(3):e229-34. PubMed ID: 27312586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-intensive versus dose-control chemotherapy for high-grade osteosarcoma: a meta-analysis.
    Wang W; Wang ZC; Shen H; Xie JJ; Lu H
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1383-90. PubMed ID: 24867518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protein expression of Skp2 in osteosarcoma and its relation with prognosis].
    Liao QD; Zhong D; Chen Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):606-11. PubMed ID: 18667774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
    Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
    Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndecan-4 and fibronectin in osteosarcoma.
    Na KY; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathology; 2012 Jun; 44(4):325-30. PubMed ID: 22531343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of survivin and correlation with PCNA in osteosarcoma.
    Wang W; Luo H; Wang A
    J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of survivin expression in gallbladder carcinoma.
    Salman T; Argon A; Kebat T; Vardar E; Erkan N; Alacacıoğlu A
    APMIS; 2016 Aug; 124(8):633-8. PubMed ID: 27214404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
    Ma C; Lu B; Sun E
    Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KAI-1 expression in pediatric high-grade osteosarcoma.
    Leavey PJ; Timmons C; Frawley W; Lombardi D; Ashfaq R
    Pediatr Dev Pathol; 2006; 9(3):219-24. PubMed ID: 16944980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.